HIV vaccine

Published by

Annette Gerritsen

Published on

1 December 2016

Watch an NIAID video describing the development of HIV vaccine candidates and the launch of the NIAID-supported HVTN 702 clinical trial, the first new HIV vaccine efficacy study in seven years. HVTN 702 is testing whether an experimental vaccine regimen safely prevents HIV infection among South African adults. The regimen involves a new version of the only HIV vaccine candidate ever shown to provide some protection against the virus.

Filed under: HIV, ResearchTagged with: , , ,

No comment yet, add your voice below!

Add a Comment

Your email address will not be published. Required fields are marked *

Comment *

Name *
Email *